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Abstract
Background: Dimeticone 4% lotion was shown to be an effective treatment for head louse
infestation in two randomised controlled trials in England. It is not affected by insecticide resistance
but efficacy obtained (70-75%) was lower than expected. This study was designed to evaluate
efficacy of dimeticone 4% lotion in a geographically, socially, and culturally different setting, in rural
Turkey and, in order to achieve blinding, it was compared with a potential alternative formulation.
Methods: Children from two village schools were screened for head lice by detection combing.
All infested students and family members could participate, giving access to treatment for the whole
community. Two investigator applied treatments were given 7 days apart. Outcome was assessed
by detection combing three times between treatments and twice the week following second
treatment.
Results: In the intention to treat group 35/36 treated using dimeticone 4% had no lice after the
second treatment but there were two protocol violators giving 91.7% treatment success. The
alternative product gave 30/36 (83.3%) treatment success, a difference of 8.4% (95% CI -9.8% to
26.2%). The cure rates per-protocol were 33/34 (97.1%) and 30/35 (85.7%) respectively. We were
unable to find any newly emerged louse nymphs on 77.8% of dimeticone 4% treated participants or
on 66.7% of those treated with the alternative formulation. No adverse events were identified.
Conclusion: Our results confirm the efficacy of dimeticone 4% lotion against lice and eggs and we
found no detectable difference between this product and dimeticone 4% lotion with nerolidol 2%
added. We believe that the high cure rate was related to the lower intensity of infestation in
Turkey, together with the level of community engagement, compared with previous studies in the
UK.
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Background
It is standard practice, and ethically sound, for ran-
domised, controlled trials of new treatments to be con-
ducted in the geographic territory where the product will
eventually be used. In the case of treatments for head lice
there is an additional reason that competent authorities
require data from their home territories. In most devel-
oped countries prior use of insecticides has selected pop-
ulations of lice that have acquired resistance to one or
more active substances, mostly insecticides, so trials con-
ducted in a country or region where insecticides have not
been used extensively, or even at all, may show an out-
come that would not accurately reflect the likely outcome
in a country where insecticides are widely available.
Clinical trials in the United Kingdom (UK) necessarily
rely upon volunteer participants who may be scattered
throughout a community. This means that those individ-
uals may be effectively treated but, because of the close
nature of much of childhood play, the children taking part
in the studies may come into close contact with others
who have head lice, with the result they become reinfested
either during the trial or soon after its completion. Rein-
festation within the family may occur readily in normal
circumstances but, because all household members either
participate or are treated in UK clinical studies, reinfesta-
tion within the study period can often be identified as
coming from outside contacts. With this prospect in mind
our previous clinical studies conducted in the UK have
always included a provision for recognising reinfestation
during the course of a trial, by means of a selective algo-
rithm based upon the number of lice found and the devel-
opmental stage of those lice [1-3]. However, it is not
selective enough to be able to identify reinfestation at
intensity greater than permitted by the algorithm.
In contrast with the UK, clinical trials conducted in devel-
oping countries often engage whole communities in the
process of therapy. This has a number of advantages. For
the community it provides access for all members of the
community to that aspect of healthcare, irrespective of
their socio-economic status, reducing the risk of ongoing
transmission of an infectious agent, as well as reducing
the level of morbidity resulting from that infection. This
kind of study has been reasonably successful for control of
lice and other infestations when a study cohort comprises
a whole community on a single intervention [4,5]. We
have previously worked with several village communities
in Manisa province, Turkey, on a variety of internal and
external parasites [6-9]. The villagers appreciate the health
input and there is a high level of participation in each
investigation.
Turkey has a plethora of lotions, crème rinses, and sham-
poos based on permethrin or d-phenothrin but no treat-
ment or product that, by virtue of its dominant position
in the market or outstanding effectiveness, could be con-
sidered a "gold standard" to be used for comparison with
new products in any clinical study conducted there.
Dimeticone 4% lotion has recently (spring 2008) been
approved by the Turkish competent authority for sale to
the public. This study enabled the product to be evaluated
for efficacy in a socially and geographically different pop-
ulation from those involved in previous investigations. It
also evaluated the efficacy of the dimeticone 4% lotion in
comparison with an alternative dimeticone 4% lotion
product containing 2% nerolidol as a surface tension
modifier, which was being considered as an alternative to
the original product based on in vitro data, in a ran-
domised, controlled, assessor blind, parallel group, com-
munity study.
Methods
Objectives
The study was designed to evaluate the efficacy of dimeti-
cone 4% lotion against head louse infestation in a differ-
ent study population from previously. It was also
designed to compare dimeticone 4% lotion with a poten-
tial alternative silicone formulation. It was anticipated
that for both objectives the risk of reinfestation would be
minimised, compared with previous investigations, by
offering treatment to the whole community.
Participants
The study was based around two rural village schools in
Manisa province, western Turkey. The villages were
selected because the schools were large enough to provide
a sufficient number of participants but small enough for
the investigation team to screen all students for head lice
during a single day. One school in the village of Osman-
cali serves approximately 20 small villages and communi-
ties in the locality and children are bussed in daily. The
other school in Maldan village serves only that commu-
nity and a few adjacent farms. Children in each of the
schools were screened for presence of live lice using plastic
detection combs ("PDC", KSL Consulting, Denmark) [6].
Infested children were provided with an information
sheet to take home and subsequently the family of every
child found positive for head lice was visited at home by
at least one investigator and the community nurse. A
standard consent and assent procedure was followed. All
infested family members were able to participate in the
study.
All enrolled participants provided baseline data on age,
gender, hair characteristics, and previous pediculicide use.
The lower age limit was 4 years; there was no upper limit.
Treatments and assessments were conducted in the
school, which ensured access to all participants. When
children were not available for assessment on the assignedBMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
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school day a follow up was arranged by the locality nurse
to visit them at home. No payment was offered for partic-
ipation.
Inclusion and exclusion criteria for this study were essen-
tially the same as we have used previously [1-3], excluding
potential participants with: known sensitivity to any com-
ponent of treatment; secondary bacterial infection or
other chronic scalp condition; bleached, coloured, or per-
manently waved hair within the previous four weeks; use
of pediculicide within two weeks or co-trimoxazole or tri-
methoprim antibiotics within four weeks (either of which
could affect the viability of any lice remaining on the
head). Pregnancy and breast feeding were also exclusion
factors, as were having participated in another clinical
study within 1 month or prior participation in this study.
Ethics
The study was granted ethical approval by the ethics com-
mittee of the Medical School of Celal Bayar University,
Manisa, Turkey (Study 025, 14/02/2007). Approval was
also obtained from the Board of Education covering that
part of Manisa province as well as individual school
authorities prior to commencement. None of the children
attending the two schools was older than 14 years of age
so parents signed a form giving written consent for them
to participate and stating they understood the purpose of
the study as set out in the information leaflet. All the chil-
dren also gave written assent prior to enrolment.
The study was conducted in conformity with the princi-
ples of the Declaration of Helsinki and of European Direc-
tive 2001/20/EC.
Treatment
Two physically similar silicone lotions were used for this
study. Both were based on 4% dimeticone in a cylcome-
thicone solvent. The original dimeticone 4% lotion
(Hedrin® 4% lotion, Thornton & Ross Ltd, Huddersfield,
UK) was compared with essentially the same mixture into
which 2% nerolidol had been incorporated. Nerolidol is
a linear sesquiterpene alcohol that has properties that may
allow it to modify the surface tension of the lotion and
facilitate its penetration into the breathing apparatus of
the louse and its egg. Tests in vitro indicted that it had
greater ability to enter the breathing system of the louse
eggs, resulting in reduced risk of hatching by a factor of
about 30%.
Participants were randomised to receive either dimeticone
4% lotion or dimeticone 4% lotion with nerolidol 2%,
each with two applications 7 days apart. As in previous
studies of dimeticone 4% lotion the products were
applied by members of the investigation team. Sufficient
product was applied to dry hair to moisten the whole
scalp and length of the hair. Treatment was applied at the
end of the school day, left to dry naturally, and washed off
the following morning at home, using a non-medicated
shampoo supplied by the investigation team. Family
members who were found with lice but were unable to
participate for any reason were provided with dimeticone
4% lotion for self administration in order to reduce the
risk of reinfestation to the study group. Only sixteen peo-
ple reported having ever used a pediculicide, six had used
permethrin about 2 months previously with varying
results; the others had not been treated for between 6
months and 6 years.
Assessment of Outcome
At initial diagnosis an assessment of intensity of infesta-
tion was based on the rapidity with which lice were found
during the initial combing. This measure was used previ-
ously [1-3] as a guideline during post-study evaluations of
outcome: heavy = >1 louse with the first stroke of the
comb, medium = 1 louse with the first stroke of the comb,
light = 1 louse found only after 5-6 strokes of the comb.
Each participant was assessed for presence of lice on five
occasions, days 1, 2, 6, 9, and 14 after the first application
of treatment, using the "PDC" comb on dry hair in the
same way as the children were initially screened in the
schools. The purpose of the additional combing immedi-
ately following the first treatment (i.e. a combing on days
1 and 2 rather than on day 1 or day 2 as have been used
in other studies) was to enable the investigators a better
opportunity to find any newly hatched nymphs in rela-
tion to evaluation of the first primary outcome measure,
the ovicidal effect of the treatments, defined as no nym-
phal lice emerging from eggs between treatments. the
other primary outcome measure, elimination of live lice
following the second application of treatment, that is, no
lice present on days 9 and 14, was monitored by combing
on days 9 and 14 as in previous studies [1-3].
Interim combing assessments employed the same
approach as previously, drawing the comb 2-3 times
through each section of hair. This level of dry combing has
minimal intervention effect because, if no lice are found
the combing cannot affect the outcome of treatment in
any way. If lice are found the non-intensive combing
removes only a proportion of any lice present, but allows
identification of treatment failure or possible reinfesta-
tion at the earliest opportunity. The day 14 assessment
involved more extensive combing than on other days to
ensure no live lice were present. Non-participating family
members with lice who self treated were also checked if
they assented. This allowed us to confirm whether their
treatments had been successful and to understand the cir-
cumstances that could lead to reinfestation. ReinfestationBMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
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was defined using an algorithm described previously
[2,3].
Sample size and Randomisation
Previous studies conducted in the UK have demonstrated
efficacy rates for dimeticone 4% lotion of around 70%
and no newly emerged nymphs have been found on
approximately 50% of participants after first treatment
[1,3]. Based on group sizes used previously a sample size
of 31 per group was considered to have at least 80% power
to detect (with 95% confidence) a difference of 35%
between the products in not finding newly hatched
nymphs or in efficacy rates based on elimination of infes-
tation. The actual sample sizes of 36 per group made
allowance for dropout. Treatment allocation was in bal-
anced blocks of 12 predetermined using a computer gen-
erated list (http://www.randomization.com, 17 March
2008). Allocation at the point of delivery was made from
instruction sheets enclosed in opaque, sealed, sequen-
tially numbered envelopes distributed to the investigators
in batches of 12. As each participant was enrolled the
investigator on site selected the next available numbered
envelope from the allocation and the treatment was then
applied from one of two series of numbered bottles.
Randomisation was by individual so if more than one
member of a family was enrolled it was possible for them
to receive different treatments. This approach for studies
on head louse infestation has been the accepted randomi-
sation methodology by the Medicines and Healthcare
products Regulatory Agency (MHRA) in the UK, whereas
the US Food and Drug Administration (FDA) have been
inclined towards cluster randomisation by family. How-
ever, the latter methodology is generally not practical for
a small proof of concept study as there is a need to stratify
households according to number of participants, and pos-
sibly even intensity of infestation of individuals within
the households, and the working assumption is generally
that all the household units are independent and the par-
ticipants within a household are correlated. A statistical
difficulty arises on how to deal with within-household
correlation because some of the evidence (unpublished)
from previous studies indicates that for some households
there is no within-household correlation. Consequently,
it was decided at an early stage to continue to use ran-
domisation by individual.
As the two products were physically similar the allocation
was essentially blinded to participants at the point of
delivery. In order to avoid contamination bias all study
treatments were applied by investigators and the bottles of
study medication returned to the centre for weighing after
single use. Assessments were performed by different inves-
tigators from those who conducted the initial screening,
enrolment, and treatment of each child in order to reduce
the possibility of bias.
Statistical methods
For presence/absence variables a Fisher exact test was
used. Differences in success rates between the treatment
outcomes for the two preparations were quantified by the
95% confidence interval, calculated using a normal
approximation to the binomial distribution. For graded
or semi-continuous variables, Kruskal-Wallis analysis of
variance was used, which as only two groups were tested
was equivalent to using the Mann-Whitney U test.
Results
Recruitment and participant flow
The study was conducted throughout April and May 2008.
During this time 72 participants from 57 families distrib-
uted between 12 villages were recruited to receive either
dimeticone 4% lotion or the alternative silicone prepara-
tion (Figure 1). Nineteen participants came from Osman-
cali village and 34 from Maldan, but no more than four
came from any one of the other ten villages involved, each
of which was served by Osmancali School. Thirteen fami-
lies had two participants in the study and one family three
participants. Where multiple family members were
included in the analysis, five families, with all members
treated using the same product, occurred in each of the
treatment groups. Only four families had members in dif-
ferent treatment groups. Sixty nine participants completed
the study as required by the protocol.
Baseline data
Demographic characteristics of the study population at
baseline are given in Table 1. Overall the groups were sim-
ilar with no significant differences. However, in this study
there was a non-significant trend for a greater proportion
of children with fine hair and light infestation compared
with previous studies conducted in the UK [1,3]. Both
these factors are to some extent subjective to evaluate and
could be influenced by the hair characteristics and the rel-
ative experience of the investigator.
Outcomes
Seventy two participants were enrolled in the study. Of
these 35/36 (97.2%) of the dimeticone 4% group were
free from lice on both assessment days (days 9 and 14)
following the second treatment on day 7. However, two
people were subsequently excluded from per-protocol
evaluations, one because it was found they had been
treated with a non-study pediculicide product during the
study and the other because they had used a treatment
only 2 days prior to enrolment but had not informed
investigators. In the group treated with the dimeticone
and nerolidol preparation, 31/36 participants (86.1%)
were found to have no lice at both assessments after theBMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
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second treatment but one person was excluded from per-
protocol evaluation because they used a non-study prod-
uct during the study. This resulted in a worst case analysis
outcome of 33/36 (91.7%) successful treatments for
dimeticone 4% lotion and 30/36 (83.3%), one of which
was considered cured but subsequently reinfested, for the
alternative dimeticone 4% preparation with 2% nerolidol
added, with protocol violators included nominally as
treatment failures. The difference, 8.4%, has a probability
of 0.478 with a 95% confidence interval of -9.8 to 26.2
and indicates no difference of activity between the prod-
ucts, but the numbers involved in the study were too
small to be conclusive. All compliant participants had
complete data sets so the per-protocol outcome was 33/34
(97.1%) and 30/35 (85.7%) respectively with successful
treatments. This provides a difference of 11.4%, which has
a probability of 0.198 with a confidence interval of -5.3 to
28.3, which also indicates no significant difference
between the treatments.
A sub-group analysis based on demographic characteris-
tics showed no difference between the groups in the rate
of cure or re-infestation in any of the subgroups analysed
apart from those with "Normal" hair for whom dimeti-
cone 4% lotion was significantly (p < 0.05) more effective
(Table 2). However, this difference can be considered a
"false positive" effect as, based on previous experience,
there is no a priori reason to expect dimeticone 4% to be
more effective when used on "Normal" hair.
Analysis of data collected at interim assessments on days
1, 2, and 6 found recently hatched nymphs on 8 partici-
pants treated using dimeticone 4% and 11 participants
treated with the alternative product, indicating that inhi-
Flowchart of subjects in study Figure 1
Flowchart of subjects in study.
Screened (n = 194) 
Not randomised (n = 122) 
 
Reasons: 
No lice (n = 110) 
Not eligible (n = 12) 
Randomised (n=72) 
Allocated alternative silicone 
(n = 36) 
Allocated dimeticone 4% lotion 
(n = 36) 
Protocol violations: 
Used insecticide (n = 1) 
Wrong 2
nd treatment (n = 1) 
Analysed ITT 
(n = 36) 
Protocol violations: 
Treated 2 days before 
enrolment (n = 1) 
Analysed Per protocol  
(n = 35) 
Analysed ITT 
(n = 36) 
Analysed Per protocol 
(n = 34) BMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
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bition of nymphs hatching after the first treatment, was
28/36 (77.8%) and 24/36 (66.7%) respectively (p = 0.85,
95% CI, -10% to 32%). In seven of the cases who had
nymphs following the first treatment with dimeticone
4%, no lice were found after the second treatment on day
7.
Amongst the subjects with lice present on days 1, 2, or 6,
there were five groups of siblings. In at least two families,
each with two participating members, another family
member was found to be infested but not enrolled. It is
not known whether those non-participants were treated
adequately, or even at all, at the commencement of the
study and could have constituted a source of reinfestation.
However, in the four families with a participating member
in each treatment group there were no treatment failures.
Of the families in which all members were treated using
the same product, four families treated with dimeticone
4% were all cleared of lice and one family had one suc-
cessful and one failed treatment; three families treated
using dimeticone 4% with nerolidol were all cured, one
family had the treatments of both participants fail, and
the family with three members had one success, one fail-
ure, and one appeared to have been reinfested after having
lice eliminated.
Two of the treatment failures were siblings from Osman-
cali the others were all from Maldan village. No two treat-
ment failures were the same age so there were no obvious
correlating factors, such as participants with lice being
playmates, or other detectable differences in overall effi-
cacy between the schools involved.
Table 1: Comparison of demographic characteristics of participants
Dimeticone 4% lotion Dimeticone + nerolidol lotion
(n = 36) (n = 36)
Age in years:
range 6 to 31 5 to 37
mean 11.4 11.6
median 10 10
number of participants (%) number of participants (%) p value
Gender:
male 9 (25.0) 7 (19.4) 0.777
female 27 (75.0) 29 (80.6)
Infestation:
light 30 (83.3) 27 (75.0) 0.670
medium 3 (8.3) 5 (13.9)
heavy 3 (8.3) 4 (11.1)
Hair length:
close cut 6 (16.7) 5 (13.9) 0.925
above ears 3 (8.3) 2 (5.6)
ears to shoulders 10 (27.8) 12 (33.3)
below shoulders 17 (47.2) 17 (47.2)
Hair thickness:
fine 17 (47.2) 14 (38.9) 0.869
average 16 (44.4) 14 (38.9)
thick 7 (19.4) 8 (22.2)
Hair curl:
straight 17 (47.2) 25 (69.4) 0.115
wavy 15 (41.7) 10 (27.8)
curly 4 (11.1) 1 (2.8)
Hair oiliness:
dry 7 (19.4) 9 (25.0) 0.813
normal 25 (69.4) 24 (66.7)
oily 4 (11.1) 3 (8.3)BMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
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Adverse events
No adverse events due to treatment or unrelated illnesses
were reported by participants in this study. There were
also no changes in concomitant medication.
Discussion
We have conducted a randomised, assessor blinded com-
parison between dimeticone 4% lotion and dimeticone
4% lotion with nerolidol 2% added. From our in vitro
work we had anticipated that using the formulation with
nerolidol could improve treatment outcome by exhibiting
a greater effect to inhibit hatching of louse eggs following
the first application of treatment. However, in this study
any difference of activity against louse eggs was either not
apparent or else not detectable due to the overall high
proportion of successful treatments using both products.
Despite the nerolidol formulation not performing as well
as anticipated, based on in vitro data, there was also no evi-
dence that addition of nerolidol to dimeticone 4% lotion
diminished its activity in any way.
Previously it was found that, although dimeticone 4%
lotion was effective to eliminate head louse infestation, a
proportion of participants in studies conducted in the UK
were not cured according to study criteria or else had been
reinfested to such a degree from contacts in the commu-
nity that the treatment was considered to have failed [1,3].
Part of the reason for this is that in recent years the preva-
Table 2: Success of treatment by sub-group (ITT population)
Dimeticone 4% lotion Dimeticone + nerolidol lotion
Sub-group n/N % n/N % p
All subjects 33/34 97.1 30/35 85.7 0.198
Sex:
males 9/9 100.0 7/7 100.0 *
females 24/27 88.9 23/28 82.1 0.705
Age:
5 to 7 5/5 100.0 3/5 60.0 0.444
8 to 10 14/14 100.0 16/19 84.2 0.244
11 to 16 12/13 92.3 8/8 100.0 *
17+ 2/2 100.0 2/2 100.0 *
Infection:
light 29/29 100.0 24/26 92.3 0.219
moderate 2/3 66.7 2/5 40.0 *
heavy 3/3 100.0 3/3 100.0 *
Hair length:
close cut 6/6 100.0 5/5 100.0 *
above ears 3/3 100.0 2/2 100.0 *
ears to shoulders 9/10 90.0 10/11 90.9 *
below shoulders 15/15 100.0 13/17 76.5 0.104
Hair thickness:
fine 10/11 90.9 10/13 76.9 0.596
medium 16/16 100.0 12/14 85.7 0.209
Thick 7/7 100.0 8/8 100.0 *
Hair curl:
straight 15/16 93.8 21/24 87.5 0.638
wavy or curly 18/18 100.0 9/11 81.8 0.136
Hair type:
normal 23/23 100.0 18/23 78.3 0.049
other 10/11 90.9 12/12 100.0 0.478
Other family member in study:
no 18/18 100.0 19/21 90.5 0.490
yes 15/16 93.8 11/14 78.6 0.316
*where no p value is specified, p = 1.0BMC Public Health 2009, 9:441 http://www.biomedcentral.com/1471-2458/9/441
Page 8 of 9
(page number not for citation purposes)
lence of infestation in the UK has probably been higher
than at any time since the 1940s and many individual
cases show intense infestation with hundreds of lice
present. However, in this study we have found that when
dimeticone lotions were used in a setting where the over-
all intensity of infestation was lower and all members of a
community diagnosed with head louse infestation had
access to treatment concurrently, it was possible to reduce
the risk of rapid reinfestation from contacts during the
course of the study.
Comparison of the data obtained in Turkey with those
from the UK [3] showed that dimeticone 4% gave a signif-
icantly more effective elimination of infestation using
worst case intention to treat analysis, in which 33/36
(91.7%) participants were free from lice after the second
treatment compared with 30/43 (69.8%) in the UK study,
a difference of 21.9% (p < 0.015, confidence interval 4%
to 40%). Per protocol outcomes of 33/34 and 30/39
respectively showed a similar difference (p < 0.013, confi-
dence interval 4% to 36%).
We found the success rate using silicone treatments in this
study was significantly better at all levels than we were
able to achieve in the UK [3]. Most demographic differ-
ences were non-significant apart from the level of inten-
sity of infestation and the coverage of treatment within
the community. This difference highlights the potential
difference of outcome likely to be encountered in con-
ducting studies in different countries and reinforces the
preference of some Western European competent author-
ities for conducting studies on "home soil" rather than in
third party countries. However, there are other factors that
influence outcome, for example in the UK study we relied
on volunteer participants who came from different places
and, although some of them did respond to advertising in
clusters, the overall coverage of each village community
was sparse. This meant that prior to recruitment there was
a greater chance respondents had longer term and more
intense infestations in the UK, where light infestations
were found in only 14/43 (32.6%) participants versus 57/
72 (79.2%) in Turkey (p < 0.0004, confidence interval
28% to 65%), and after treatment more potentially infec-
tive contacts for study participants remained untreated,
with the result that the risk of reinfestation was higher in
the UK. In this study we screened all school aged children
in the two communities, which should have identified
individuals with the highest risk of infestations, and
through them family members also with a high risk. By
eliminating lice from the highest risk group of families,
the overall risk of reinfestation from those communities
should have been reduced. However, if individuals out-
side the school groups declined screening or treatment, or
if families with potentially infested younger children did
not come forward for screening, a risk for reinfestation
remained for any participants with whom they had con-
tact.
One concern raised during earlier investigations, and fol-
lowing consumer use of silicone lotions containing
dimeticone, was that perhaps some lice, or louse infesta-
tions, are more difficult to eliminate than others. As resist-
ance is not considered a likely occurrence with dimeticone
treatment due to its physical mode of action, it was asked
whether some lice had innate potential to avoid or toler-
ate exposure to the silicone fluid compared with other
lice. It appears that what we observed was not a failure to
kill lice but rather an inability to avoid reinfestation and
prevent louse eggs from hatching. The lesson learned is
that control of head lice in a community is dependent
upon coordinated efforts to treat all infested individuals.
Treating one child, or family group, in isolation risks only
limited relief from head lice due to rapid reinfestation.
Based on our findings it may be appropriate to rethink the
strategy for management of head louse infestation in
Western Europe. Co-ordinated campaigns have been
organised in some communities in the UK, Belgium, and
Denmark using combing treatments [10], but the overall
success rate can be low unless there is a considerable sup-
port network for families dealing with the problem. Even
in Australia, where community based programmes have
operated since the 1980s [11,12] the prevalence of head
louse infestation remains high [12], probably because
people use products affected by insecticide resistance,
ineffective combing procedures, or do not have adequate
professional support. Of course, it is also necessary for all
families in the community to participate fully otherwise
there is a risk for reinfestation. Any new strategy requires
robust health promotion to communicate the need for
full participation of the community, as in a programme
conducted in the Isle of Man [13] where concerted efforts
to identify all cases during a campaign resulted in reduced
levels of infestation over the next 3-4 years. Similar effects
were seen in the early use of malathion treatments in the
late 1960s where there was a high degree of participation
managed by local health services [14-16]. These managed
programmes were so successful that the children were not
reinfested for several weeks after treatment, which led
investigators to draw the incorrect conclusion that
malathion was capable of developing a residual effect on
hair [14]. If it were possible to cover a similarly high pro-
portion of the population at risk using reliably effective
physically acting treatments like dimeticone lotions we
anticipate the overall burden of infestation in many com-
munities could be considerably reduced.
Conclusion
In a community based, randomised, assessor blinded clin-
ical trial we were unable to detect a difference in efficacyPublish with BioMed Central    and   every 
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between dimeticone 4% lotion and dimeticone 4% lotion
with nerolidol 2% added. We also found few cases with
newly hatched nymphs after the first application of either
treatment, indicating activity of the products to inhibit
hatching of louse eggs. Dimeticone 4% lotion has been
shown effective to cure head louse infestation in about
70-75% of patients in randomised trials in the UK but
treating individuals in a community where prevalence of
head lice and intensity of infestation is high often
increases the risk of apparent treatment failure through
reinfestation. Past studies have indicated that community
treatment programmes of ectoparasites and endoparasites
in Turkish villages have a high treatment success rate with
few cases of reinfestation. In this study we also found a
low level of reinfestation, probably due to the lower inten-
sity of infestation than in the UK and the high level of par-
ticipation in the study by families in the communities
involved.
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